Chapter 548: Number One in the World, Hundred Billion Dollar Club

Author: Riding a pig to dig a hole

Chapter 548: Number One in the World, Hundred Billion Dollar Club

“Artificial intelligence regulation is out!”

“Countries are planning to introduce bills to strictly control AI.”

"Technology giants held an emergency meeting to discuss and formulate standards for how to use artificial intelligence technology."

"Three Purities officially announced that they will join forces to build a large-scale model platform and start an epic transformation in the medical field."

"Breaking news! These tertiary hospitals will be connected to artificial intelligence services, and the era of AI medical treatment is coming."

"Dami is involved in the AI ​​war, large-scale domestic models are being released, and the AI ​​track is becoming popular around the world."

"Mabuse entered the big model, bought 10,000 GPUs, and shorted the graphics card market."

"After discovering that his works were used to train artificial intelligence, Eagle Country artists filed a class action lawsuit against the relevant AI companies."

“After the original painting team of a game company introduced AI software, they laid off 2/3 of their employees, saving 200,000 yuan in monthly costs and increasing efficiency by 50%.”

“A Putian shoe factory laid off its marketing team and used AI to create tens of thousands of advertisements for distribution through channels.”

“A leading fund company announced that it will fully explore the application of artificial intelligence, and AI stock trading may become a reality.

"The singularity is coming, and AI may start a new round of technological revolution."

News related to artificial intelligence are constantly breaking out, and netizens are stunned.

"Nima AI has come out to speculate in stocks? Isn't this the same as plug-ins in games? From now on, retail investors will completely become leeks."

"It's hard to say. Since they are all game plug-ins, there must be some who sell them. You can just buy them with money."

"The rich man upstairs gave me 50, I'm cheating."

"These companies are crazy, and they want to have something to do with AI, even if they can't even deal with it."

"Domestic AI is still not good. Except for Sanqing, no one can do To C. The actual level is not transparent at all and cannot be compared with ChatGPT."

“Actually, it’s okay to be able to do To B AI painting functions like Midjournry. However, the AI ​​led by these leading manufacturers is all about empowering the original business and running in their own circles. It has no technical content at all, and the investment is not as high.

It cannot be compared with foreign countries.”

"Why do I feel that bosses in traditional industries are embracing AI faster? In the future, except for large companies, other companies will be able to fire their advertising and marketing teams."

"In addition to artists, designers are also going to lose their jobs. Our company forces the design team to learn AI, and those who can't learn it will be fired. In the past, at least five designers needed to complete the work, but now only one designer can complete it using AI.

.”

"Programmers are slightly better, because most people can't understand code. Even if AI is used, coders still need to operate and communicate. Moreover, we have information security considerations. At present, it is only used to consult some questions, and the data cannot be transferred yet.

Upload it to AI to avoid leaking secrets."

"Another point is that there are no copyright issues for the drawings and copywriting for the time being, but our code needs to be checked for plagiarism. If you directly copy the code generated by chatGPT, there will be copyright risks."

"Our clothing brand is currently using AI models in e-commerce channels. It is much easier to use than real models. It does not take several days to take photos. It only takes one click to generate them, saving tens of thousands of yuan in shooting costs.

, this AI is really a good thing.”

"Damn, now in the weekly department meeting, after the work report, everyone has to take turns to analyze their own experience in using AI tools. To be honest, under the flood of technology, all workers are just ants, and they can only join in actively or passively.

There is no room for resistance at all.”

"Hey, I am anxious every day now. Every time I use AI to draw, if the drawing drawn by AI is terrible, I will be very happy and happy all day long. Then if I see other people using AI to draw very exquisite

If I look at the picture, I will fall into anxiety again, forming an endless loop. I am really hopeless."

"The market is getting more and more complicated, and workers are becoming more and more stupid. Everyone says they are not interested in AI, but privately everyone is crazy about learning AI."

"That's right, these stupid colleagues, every time the company holds an AI lecture, not one of them wants to go. I look back to see if the tickets are available."

"The only ones who are still resisting AI are probably the original painters. I think their resistance to AI painting has never weakened. What about 'stitch monsters' and 'corpse splicing'? I guess they will make a big splash sooner or later."

of."

"They, haha, I'm not saying that, the wave of AI is coming, and everyone can't resist it. They are just trying to control the situation."

"We are all workers. We are just struggling between our resistance to AI and the company's rigid requirements. We are making money, not shabby."

“I’m a little excited to think about witnessing the beginning of a new AI era.”

"I have talked about the six major principles of supervision, but I have not mentioned the most critical ones, such as whether AI painting is an infringement?"

"You know, this probably requires a case to be made before detailed regulations can be issued. You see, artists and companies in Eagle Country are suing on their own. When we come here too, the rules will probably be finalized."

"Right now, we are all trying to cross the river by feeling the stones. We can only come up with guidelines. No one can say the specifics. We have to discuss things on a case-by-case basis."

"Actually, I am more interested in Sanqing's AI-connected hospitals. There are not many pilot hospitals on the list, no more than ten, and they are all non-top tertiary hospitals in first- and second-tier cities."

"It's great, but it didn't write down the specific implementation date. It gave a rather vague time, saying it would be after the Spring Festival."

"It also takes time to implement it specifically. Coordination from top to bottom, standardization of processes, and access to big data. It can be done within a month or two, which is already very impressive."

"Xiaomei can treat us now, but it can only be used as a reference. It is for informal purposes. When it is officially connected to the hospital, she can actually see doctors and prescribe medicine. Let's wait and see."

Netizens have different opinions and say whatever they want, but everyone is clearly aware of it.

AI has completely evolved from an arms race between big companies to a workplace revolution that affects the life and death of every ordinary worker.

The work of destroying you has nothing to do with you.

Only by embracing AI can we have a future.

They must keep up with this trend in order to have a place in the workplace of the new era.

With the promotion of Sanqing, AI technology will also penetrate into the medical field and truly enter people's lives in a subtle way.

****

Kunshi, Sanqing headquarters.

Wei Kang was sitting in a large office chair, browsing the latest news.

As a company CEO, his focus is naturally more professional than ordinary people.

"Hundreds of billions of funds have been poured into the AI ​​medical field, and listed companies are rushing to deploy. Haha, they are following quite quickly."

"Every listed pharmaceutical company is frantically seizing on this opportunity and taking advantage of the upcoming upgrade of the pharmaceutical industry to realize commercialization."

"AI medical imaging has become the forefront of AI medical commercialization. There are many companies deploying in-hospital informatization, as well as automated pharmacy companies. In addition, AI-assisted drug design is also very popular among pharmaceutical companies."

"In fact, AI medical treatment has always been very popular. There are countless waves of enthusiasm in this area in China. Unfortunately, it is in a situation where it is not popular. Until now, Sanqing's diagnostic AI turned out to be a breakthrough.

They point the way."

"Compared with intelligent driving and general AI, AI medical treatment faces very serious ethical issues, which limits its height and development. It must be supervised by doctors before it can be truly implemented."

"Medical data is also a major pain point. High-quality, diverse and well-annotated data is the main technical bottleneck. These companies do not have their own data pools and have to cooperate with hospitals to obtain data. This involves a privacy protection issue.

.If Sanqing did not have the private domain data pool of Longtu, it would probably be difficult to move forward."

"As for algorithm barriers, these companies use general open source AI, and then make some improvements according to their own business. They have no unique skills. They are completely different from Sanqing, and the threat is not great."

"AI cannot yet replace doctors, it can only play an auxiliary role. After all, a major difficulty in AI-integrated medical care is supervision and accountability. We can only move forward step by step."

"Start with the function of auxiliary doctors, and use strong analytical and decision-making capabilities to participate in all aspects of pre-hospital, in-hospital, and post-hospital processes to promote the rational allocation of medical resources and truly serve doctors and patients."

"This is the best path AI can take at the moment."

After reading the industry news, he turned his attention to the freshly released financial reports.

The financial reports came out later and later each year, and they were not delivered to his desk until just before the Chinese New Year.

But since the numbers in the financial report were so pretty, he didn't mind too much.

This is already the seventh year, and it still maintains rapid growth and has actually exceeded the 100 billion U.S. dollar mark, reaching 100.1 billion.

In addition to inherent revenue, compared with the previous year, performance growth mainly lies in two major areas.

One is the launch of artificial blood, which has alleviated the global blood crisis and is widely sought after. The other is the domestic business of ultrasonic scalpels and endoscopes. With the support of policies, it has occupied the majority of the domestic market.

Coupled with the overseas listing of Xiaofening and the large-scale purchases by all parties, this brilliant performance was achieved.

"It's a good risk. 100.1 billion is an extra 100 million. If it's just a little bit short, we won't be able to pass." Thinking of this, Wei Kang couldn't help but call it a fluke.

"Oral insulin was still in the clinical stage last year and will not be launched until this year. Otherwise, if the performance of this flagship drug is added, it is estimated that another 10 billion will be added."

"Although there is not a big difference between 100 billion and more than 90 billion, they sound completely different."

"Now, compared to Johnson & Johnson and Pfizer, it's a little higher."

Wei Kang looked at the financial reports of his friends and couldn't help but smile with relief.

"Last year, Johnson & Johnson's revenue was 97.8 billion U.S. dollars. In comparison, Sanqing's revenue was more than 2 billion U.S. dollars. The difference is not big. It is a narrow victory. If it were a little worse, it is likely to be overtaken by the other party."

"As for Pfizer, we have also surpassed it in the pharmaceutical field. They lack the device business, and they may not be able to catch up even if they try to catch up."

“Not only did Sanqing surpass Pfizer in terms of pharmaceuticals, it also completely surpassed Johnson & Johnson in terms of total revenue, finally reaching the top spot in the world.”

"Not only that, no pharmaceutical company has ever achieved revenue of over 100 billion before. The third liquidation hit a record high and broke the record of the medical industry."

"The world's number one pharmaceutical company and the first pharmaceutical company with revenue exceeding 100 billion, Sanqing has single-handedly raised the revenue ceiling of the industry."
To be continued...